Literature DB >> 7583495

Studies of the course and outcome of schizophrenia in later life.

C I Cohen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583495     DOI: 10.1176/ps.46.9.877

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


× No keyword cloud information.
  6 in total

Review 1.  Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients.

Authors:  Jeffrey Rado; Philip G Janicak
Journal:  Drugs Aging       Date:  2012-10       Impact factor: 3.923

Review 2.  Co-occurring depressive symptoms in the older patient with schizophrenia.

Authors:  John W Kasckow; Sidney Zisook
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Quality of life, gender and schizophrenia: a cross-national survey in Canada, Cuba, and U.S.A.

Authors:  V L Vandiver
Journal:  Community Ment Health J       Date:  1998-10

Review 4.  Aripiprazole for late-life schizophrenia.

Authors:  Jeffrey Rado; Philip G Janicak
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

5.  Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.

Authors:  John Kasckow; Nicole Lanouette; Thomas Patterson; Ian Fellows; Shahrokh Golshan; Ellen Solorzano; Sidney Zisook
Journal:  Int J Geriatr Psychiatry       Date:  2010-02       Impact factor: 3.485

6.  Suicide Behavior and Its Predictors in Patients with Schizophrenia in Ethiopia.

Authors:  Mohammed Ayalew; Semira Defar; Yared Reta
Journal:  Schizophr Res Treatment       Date:  2021-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.